Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Platelet reactivity and response to aspirin in subjects with the metabolic syndrome.

Vaduganathan M, Alviar CL, Arikan ME, Tellez A, Guthikonda S, DeLao T, Granada JF, Kleiman NS, Ballantyne CM, Lev EI.

Am Heart J. 2008 Nov;156(5):1002.e1-1002.e7. doi: 10.1016/j.ahj.2008.08.002.

PMID:
19061719
2.

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.

Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Luzak B, Kropiwnicka A, Drzewoski J.

Thromb Res. 2004;113(2):101-13.

PMID:
15115665
3.

Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.

Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.

Thromb Haemost. 2008 Jul;100(1):83-9. doi: 10.1160/TH07-10-0590.

PMID:
18612542
4.

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, Granada JF, Dong JF, Kleiman NS, Lev EI.

J Am Coll Cardiol. 2008 Aug 26;52(9):743-9. doi: 10.1016/j.jacc.2008.05.031.

5.

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.

Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF, Kleiman NS.

J Thromb Haemost. 2007 Mar;5(3):490-6.

6.

Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.

Lev EI, Ramabadran RS, Guthikonda S, Patel R, Kleiman A, Granada JF, DeLao T, Kleiman NS.

Am J Cardiol. 2007 Jan 1;99(1):124-8. Epub 2006 Nov 9.

PMID:
17196475
7.

Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".

Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, Davì G, Patrono C.

J Am Coll Cardiol. 2009 Feb 24;53(8):667-77. doi: 10.1016/j.jacc.2008.10.047.

9.

Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.

Paniccia R, Antonucci E, Gori AM, Marcucci R, Poli S, Romano E, Valente S, Giglioli C, Fedi S, Gensini GF, Abbate R, Prisco D.

Am J Clin Pathol. 2007 Jul;128(1):143-9.

PMID:
17580282
10.

Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome.

Restituto P, Colina I, Varo JJ, Varo N.

Am J Physiol Endocrinol Metab. 2010 May;298(5):E1072-7. doi: 10.1152/ajpendo.00728.2009. Epub 2010 Mar 2.

11.

Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2).

Blais N, Pharand C, Lordkipanidzé M, Sia YK, Merhi Y, Diodati JG.

Thromb Haemost. 2009 Aug;102(2):404-11. doi: 10.1160/TH09-02-0126.

PMID:
19652893
12.

Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.

Nielsen HL, Kristensen SD, Thygesen SS, Mortensen J, Pedersen SB, Grove EL, Hvas AM.

Thromb Res. 2008;123(2):267-73. doi: 10.1016/j.thromres.2008.03.023. Epub 2008 May 21.

PMID:
18499236
13.

Aspirin's effect on platelet inhibition in migraineurs.

Jesurum JT, Fuller CJ, Murinova N, Truva CM, Lucas SM.

Headache. 2012 Sep;52(8):1207-18. doi: 10.1111/j.1526-4610.2012.02143.x. Epub 2012 Apr 5.

PMID:
22486810
14.

Dose- and time-dependent antiplatelet effects of aspirin.

Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P.

Thromb Haemost. 2006 Apr;95(4):652-8.

PMID:
16601836
15.

The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.

DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA.

Diabetes. 2007 Dec;56(12):3014-9. Epub 2007 Sep 11.

16.

Effects of dexibuprofen on platelet function in humans: comparison with low-dose aspirin.

González-Correa JA, Arrebola MM, Martín-Salido E, Muñoz-Marín J, de la Cuesta FS, De La Cruz JP.

Anesthesiology. 2007 Feb;106(2):218-25.

PMID:
17264714
17.

Methods for the measurement of platelet function.

Michelson AD.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):20A-26A. doi: 10.1016/j.amjcard.2008.11.019. Review.

PMID:
19166709
18.

Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry.

Hübl W, Assadian A, Lax J, Meixner U, Fang IF, Hagmüller G, Panzer S, Bayer PM.

Thromb Res. 2007;121(1):135-43. Epub 2007 Apr 30.

PMID:
17467777
19.

Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method.

Tabuchi A, Taniguchi R, Takahashi K, Kondo H, Kawato M, Morimoto T, Kimura T, Kita T, Horiuchi H.

Circ J. 2008 Mar;72(3):420-6.

20.

Comparison of four laboratory methods to assess aspirin sensitivity.

McGlasson DL, Fritsma GA.

Blood Coagul Fibrinolysis. 2008 Mar;19(2):120-3. doi: 10.1097/MBC.0b013e3282f40dc2.

PMID:
18277132

Supplemental Content

Support Center